Bellevue F.(L)-B.Obesity Sol.I GBP/ LU0767968745 /
| NAV2024-04-23 | Chg.+3.3700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 476.6800GBP | +0.71% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | - | - | - | - | - | - | - | - | -2.83 | - |
| 2017 | 5.61 | 8.44 | -0.94 | -1.65 | -3.58 | 6.86 | 1.30 | 7.09 | -4.83 | -4.86 | -0.70 | 1.06 | +13.30% |
| 2018 | 2.59 | -2.52 | -2.34 | -3.56 | 7.69 | 0.91 | 6.85 | 6.01 | -1.60 | -14.62 | 4.11 | -10.52 | -9.26% |
| 2019 | 9.50 | 3.15 | 3.07 | -6.71 | -0.99 | 8.18 | 2.40 | -2.59 | -4.62 | 1.51 | 11.41 | -1.10 | +23.79% |
| 2020 | -5.01 | 1.08 | -5.20 | 12.88 | 12.28 | 3.88 | -7.05 | -0.87 | 3.10 | -4.08 | 8.36 | 1.47 | +20.05% |
| 2021 | 3.99 | -4.13 | -4.25 | 3.80 | -1.68 | 8.14 | 2.42 | 3.12 | -3.78 | -1.82 | -0.50 | -1.99 | +2.51% |
| 2022 | -11.35 | -3.05 | 7.18 | -3.71 | -2.96 | 5.70 | 3.50 | 2.12 | 2.55 | 3.50 | 2.72 | -4.96 | -0.35% |
| 2023 | -0.18 | -5.11 | -0.97 | 0.35 | -0.64 | -3.04 | -0.83 | 0.42 | -0.35 | -6.34 | -0.63 | 1.52 | -14.97% |
| 2024 | 2.62 | 4.04 | 2.67 | -2.02 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.39% | 12.94% | 13.58% | 20.04% | 23.08% |
| Sharpe ratio | 2.15 | 0.80 | -0.68 | -0.30 | 0.03 |
| Best month | +4.04% | +4.04% | +4.04% | +8.14% | +12.88% |
| Worst month | -2.02% | -6.34% | -6.34% | -11.35% | -11.35% |
| Maximum loss | -4.34% | -5.61% | -15.07% | -26.52% | -26.52% |
| Outperformance | -3.30% | - | -2.16% | -17.44% | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue F.(L)-B.Obesity Sol.I2 ... | reinvestment | 164.1600 | -2.43% | -4.62% | |
| Bellevue F.(L)-B.Obesity Sol.I U... | reinvestment | 560.8500 | -5.48% | -15.68% | |
| Bellevue F.(L)-B.Obesity Sol.I E... | reinvestment | 702.1300 | -2.56% | -5.02% | |
| Bellevue F.(L)-B.Obesity Sol.I C... | reinvestment | 450.0800 | -3.18% | -16.27% | |
| Bellevue F.(L)-B.Obesity Sol.I G... | reinvestment | 476.6800 | -5.26% | -6.14% | |
| Bellevue F.(L)-B.Obesity Sol.B U... | reinvestment | 502.8600 | -6.14% | -17.43% | |
| Bellevue F.(L)-B.Obesity Sol.B C... | reinvestment | 401.3800 | -3.85% | -18.01% | |
| Bellevue F.(L)-B.Obesity Sol.B E... | reinvestment | 627.2300 | -3.24% | -7.00% |
Performance
| YTD | +7.41% | ||
|---|---|---|---|
| 6 Months | +6.89% | ||
| 1 Year | -5.26% | ||
| 3 Years | -6.14% | ||
| 5 Years | +25.80% | ||
| Since start | +31.25% | ||
| Year | |||
| 2023 | -14.97% | ||
| 2022 | -0.35% | ||
| 2021 | +2.51% | ||
| 2020 | +20.05% | ||
| 2019 | +23.79% | ||
| 2018 | -9.26% | ||
| 2017 | +13.30% | ||
